BIOGEN INC
HQ - Cambridge, MA
Summary
Biogen develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.
Deals Overview
Total Deals9
Valued Deals9
Total Value£ 12.63 B
Avg. Deal Size£ 1.40 B
Senior Management
Michel Vounatsos
CEO
Christopher Viehbacher
President and CEO
Michael McDonnell
CFO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.